Dopaminergic modulation of cognitive control: Distinct roles for the prefrontal cortex and the basal ganglia

Current Pharmaceutical Design

Volumn 16, Issue 18, 2010, Pages 2026-2032

  van Schouwenburg, Martine ^a,b   Aarts, Esther ^a,b   Cools, Roshan ^a,b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Parkinson's disease; Pharmacological fmri; Task switching; Working memory

Indexed keywords

BROMOCRIPTINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHYLPHENIDATE;

ARTICLE; ATTENTION; BASAL GANGLION; COGNITION; DISTRACTIBILITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMPULSIVENESS; LEARNING; MOTIVATION; MOTOR PERFORMANCE; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE; WORKING MEMORY; ANIMAL; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROCEDURES; SHORT TERM MEMORY;

ANIMALS; BASAL GANGLIA; COGNITION; DOPAMINE; HUMANS; MAGNETIC RESONANCE IMAGING; MEMORY, SHORT-TERM; PREFRONTAL CORTEX;

EID: 77953490967     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210791293097     Document Type: Article

References (83)

1. Baddeley AD. Working Memory. Oxford: Clarendon Press 1986.
2. Jacobsen C. Studies of cerebral functions in primates. Comp Psychol Monographs 1936; 13: 1-60.
3. Malmo R. Interference factors in delayed response in monkeys after removal of frontal lobes. J Neurophysiol 1942; 5: 295-308.
4. Chao L, Knight R. Human prefrontal lesions increase distractibility to irrelevant sensory inputs. NeuroReport 1995; 6(12): 1605-10.
5. Fuster J, Alexander G. Neuron activity related to short-term memory. Science 1971; 173: 652-4.
6. Miller E, Erikson C, Desimone R. Neural mechanisms of visual working memory in prefrontal cortex of the macaque. J Neurosci 1996; 16: 5154-67.
7. Curtis C, D'Esposito M. Persistent activity in the prefrontal cortex during working memory. Trends Cogn Sci 2003; 7(9): 415-23.
8. Desimone R, Duncan J. Neural mechanisms of selective visual attention. Annu Rev Neurosci 1995; 18: 193-222.
9. Miller E, Cohen J. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001; 24: 167-202.
10. Gazzaley A, Rissman J, Cooney J, Rutman A, Seibert T, Clapp W, et al. Functional interactions between prefrontal and visual association cortex contribute to top-down modulation of visual processing. Cereb Cortex 2007; 17 (Suppl 1): i125-35.
11. Epstein R, Kanwisher N. A cortical representation of the local visual environment. Nature 1998; 392(6676): 598-601.
12. Yoon JH, Curtis CE, D'Esposito M. Differential effects of distraction during working memory on delay-period activity in the prefrontal cortex and the visual association cortex. NeuroImage 2006; 29(4): 1117-26.
13. rd ed. Cambridge: Cambridge University Press 2008.
14. Brozoski TJ, Brown R, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in the prefrontal cortex of rhesus monkeys. Science 1979; 205: 929-31.
15. Sawaguchi T, Matsumura M, Kubota K. Effects of dopamine antagonists on neuronal activity related to a delated response task in monkey prefrontal cortex. J Neurophysiol 1990; 63(6): 1401-12.
16. Sawaguchi T, Matsumura M, Kubota K. Catecholaminergic effects on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol 1990; 63(6): 1385-99.
17. Sawaguchi T, Goldman-Rakic PS. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991; 251: 947-50.
18. Luciana M, Depue RA, Arbisi P, Leon A. Facililtation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 1992; 4(1): 58-68.
19. Mehta MA, Sahakian BJ, McKenna PJ, Robbins TW. Systematic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology 1999; 146: 162-74.
20. Gibbs SE, D'Esposito M. A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory. Psychopharmacology 2005; 180(4): 644-53.
21. Gibbs SE, D'Esposito M. Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation. Cogn Affect Behav Neurosci 2005; 5(2): 212-21.
22. Gibbs SE, D'Esposito M. A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory. Neuroscience 2006; 139(1): 359-71.
23. Mattay VS, Berman KF, Ostrem JL, Esposito G, Van Horn JD, Bigelow LB, et al. Dextroamphetamine enhances 'neural network-specific' phyiological signals: a Positron-Emission Tomography rCBF study. J Neurosci 1996; 16(15): 4816-22.
24. Mattay VS, Callicot JH, Bertolino A, Heaton I, Frank JA, Coppola R, et al. Effects of dextroamphetamine on cognitive performance and cortical activation. NeuroImage 2000; 12(3): 268-75.
25. Mehta M, Calloway P, Sahakian B. Amelioration of specific working memory deficits by methylphenidate in a case of adult attention deficit/hyperactivity disorder. J Psychopharm 2000; 14(3): 299-302.
26. Willson MC, Wilman AH, Bell EC, Asghar SJ, Silverstone PH. Dextroamphetamine causes a change in regional brain activity in vivo during cognitive tasks: a functional magnetic resonance imaging study of blood oxygen level-dependent response. Biol Psychiatry 2004; 56(4): 284-91.
27. Servan-Schreiber D, Printz H, Cohen J. A network model of catecholamine effects: gain, signal-to-noise ratio, and behavior. Science 1990; 249: 892-5.
28. Durstewitz D, Seamans J, Sejnowski T. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 2000; 83: 1733-50.
29. Durstewitz D, Seamans JK. The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyl-transferase genotypes and schizophrenia. Biol Psychiatry 2008; 64(9): 739-49.
30. Seamans JK, Yang CR. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 2004; 74(1): 1-58.
31. Arnsten AFT. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 1998; 2(11): 436-46.
32. Zahrt J, Taylor JR, Mathew RG, Arnsten AFT. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 1997; 17(21): 8528-35.
33. Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995; 376: 572-5.
34. Arnsten AF, Goldman-Rakic PS. Noise Stress Impairs Prefrontal Cortical Cognitive Function in Monkeys. Arch Gen Psychiatry 1998; 55: 362-8.
35. Murphy FC, Arnsten AF, Goldman-Rakic PS, Roth RH. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 1996; 93(3): 1325-9.
36. Cai JX, Arnsten AF. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmac Exp Ther 1997; 282: 1-7.
37. Tipper CM, Cairo TA, Woodward TS, Phillips AG, Liddle PF, Ngan ET. Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation. Psychopharmacology 2005; 180(4): 634-43.
38. Kimberg DY, D'Esposito M, Farah MJ. Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 1997; 8: 3581-5.
39. Cools R, Gibbs S, Miyakawa A, Jagust W, D'Esposito M. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 2008; 28: 1208-12.
40. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ. Striatal dopamine and working memory. Cereb Cortex 2009; 19(2): 445-54.
41. Floresco S, Phillips A. Delay-dependent modulation of memory retrieval by infusion of a dopamine D1 agonist into the rat medial prefrontal cortex. Behav Neurosci 2001; 115(4): 934-9.
42. Phillips A, Ahn S, Floresco S. Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task. J Neurosci 2004; 14(2): 547-53.
43. 158 -met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 2003; 100(10): 6186-91.
44. Cohen MX, Krohn-Grimberghe A, Elger CE, Weber B. Dopamine gene predicts the brain's response to dopaminergic drug. Eur J Neurosci 2007; 26(12): 3652-60.
45. Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol 1996; 50: 381-425.
46. Cools AR. Role of the neostriatal dopaminergic activity in sequencing and selecting behavioural strategies: facilitation of processes involved in selecting the best strategy in a stressful situation. Behav Brain Res 1980; 1: 361-78.
47. van den Bos R, Cools A. Switching to cue-directed behavior: specific for ventral striatal dopamine but not ventral pallidum/ substantia innominata gaba as revealed by a swimming-test procedure in rats. Neuroscience 2003; 118(4): 1141-9.
48. Cools AR, Van Den Bercken JHL, Horstink MWI, Van Spaendonck KPM, Berger HJC. Cognitive and motor shifting aptitude disorder in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984; 47: 443-53.
49. Hayes AE, Davidson MC, Keele SW. Towards a functional analysis of the basal ganglia. J Cogn Neurosci 1998; 10(2): 178-98.
50. Barbeau A. Biology of the Striatum. In: Gaull G, Ed. Biology of Brain Dysfunction. New York: Plenum Press 1973; pp. 333-50.
51. Battig K, Rosvold H, Mishkin M. Comparison of the effects of frontal and caudate lesions on delayed response and alternation in monkeys. J Comp Physiol Psychol 1960; 53: 400-4.
52. Packard MG, Knowlton BJ. Learning and memory functions of the basal ganglia. Annu Rev Neurosci 2002; 25: 563-93.
53. Frank MJ. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J Cogn Neurosci 2005; 17(1): 51-72.
54. Leber AB, Turk-Browne NB, Chun MM. Neural predictors of moment-to-moment fluctuations in cognitive flexibility. Proc Natl Acad Sci USA 2008; 105(36): 13592-7.
55. Cools R, Clark L, Robbins TW. Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance. J Neurosci 2004; 24(5): 1129-35.
56. Cools R, Clark L, Owen AM, Robbins TW. Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci 2002; 22(11): 4563-7.
57. Rogers RD, Andrews TC, Grasby PM, Brooks DJ, Robbins TW. Contrasting cortical and subcortical activations produced by attentional-set shifting and reversal learning in humans. J Cogn Neurosci 2000; 12(1): 142-62.
58. Owen AM, James M, Leigh JM, Summers BA, Marsden CD, Quinn NP, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992; 115: 1727-51.
59. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW. Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia 1989; 27: 1329-43.
60. Cools R, Ivry R, D'Esposito M. The human striatum is necessary for responding to changes in stimulus relevance. J Cogn Neurosci 2006; 18(12): 1959-72.
61. Cools R, Barker RA, Sahakian BJ, Robbins TW. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 2001; 124: 2503-12.
62. Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001; 11: 1136-43.
63. Cools R, Lewis S, Clark L, Barker R, Robbins TW. L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 2007; 32: 180-9.
64. Dodds CM, Muller U, Clark L, van Loon A, Cools R, Robbins TW. Methylphenidate has differential effects on blood oxygenation level-dependent signal related to cognitive subprocesses of reversal learning. J Neurosci 2008; 28(23): 5976-82.
65. Cools R, Sheridan M, Jacobs E, D'Esposito M. Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J Neurosci 2007; 27(20): 5506-14.
66. Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, et al. Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 2009; 29(15): 4690-6.
67. Dalley JW, Fryer TD, Birchard L, Robinson ES, Theobald DE, Laane K, et al. Nucleus accumbens D2 receptors predict trait impulsivity and cocaine reinforcement. Science 2007; 315(5816): 1267-70.
68. Oswald LM, Wong DF, Zhou Y, Kumar A, Brasic J, Alexander M, et al. Impulsivity and chronic stress are associated with ampheta-mine-induced striatal dopamine release. NeuroImage 2007; 36(1): 153-66.
69. Cools R, Frank M, Gibbs S, Miyakawa A, Jagust W, D'Esposito M. Striatal dopamine synthesis capacity predicts dopaminergic drug effects on flexible outcome learning. J Neurosci 2009; 29(5): 1538-43.
70. Dodds CM, Clark L, Dove A, Regenthal R, Baumann F, Bullmore E, et al. The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory. Psychopharmacology 2009; 207(1): 35-45.
71. Collins P, Wilkinson LS, Everitt BJ, Robbins TW, Roberts AC. The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function. Behav Neurosci 2000; 114(1): 3-17.
72. Roberts AC, De Salvia MA, Wilkinson LS, Collins P, Muir JL, Everitt BJ, et al. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the wisconsin card sort test: possible interactions with subcortical dopamine. J Neurosci 1994; 14(5): 2531-44.
73. Crofts HS, Dalley JW, Van Denderen JCM, Everitt BJ, Robbins TW, Roberts AC. Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cerebral Cortex 2001; 11(11): 1015-26.
74. Pycock CJ, Kerwin RW, Carter CJ. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 1980; 286: 74-7.
75. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 2003; 23(6): 2008-13.
76. Alexander G, DeLong M, Stuck P. Parallel organisation of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9: 357-81.
77. Stephan KE, Weiskopf N, Drysdale PM, Robinson PA, Friston KJ. Comparing hemodynamic models with DCM. NeuroImage 2007; 38(3): 387-401.
78. Bogacz R, Wagenmakers EJ, Forstmann BU, Nieuwenhuis S. The neural basis of the speed-accuracy tradeoff. Trends Neurosci 2010; 33(1): 10-6.
79. Forstmann BU, Dutilh G, Brown S, Neumann J, von Cramon DY, Ridderinkhof KR, et al. Striatum and pre-SMA facilitate decision-making under time pressure. Proc Nat Acad Sci USA 2008; 105(45): 17538-42.
80. Schultz W. Multiple reward signals in the brain. Nat Rev 2000; 1: 199-207.
81. Redgrave P, Prescott TJ, Gurney K. The basal ganglia: a verte-brate solution to the selection problem? Neuroscience 1999; 89(4): 1009-23.
82. Nagano-Saito A, Leyton M, Monchi O, Goldberg YK, He Y, Dagher A. Dopamine depletion impairs frontostriatal functional connectivity during a set-shifting task. J Neurosci 2008; 28(14): 3697-706.
83. Aarts E, Roelofs A, Franke B, Rijpkema M, Fernandez G, Helmich RC, et al. Striatal dopamine mediates the interface between motivation and cognition in humans: Evidence from genetic imaging. Neuropsychopharmacology (in press).